Remington Medical, a U.S. medical device manufacturing company, has launched VascuChek, a modern wireless, handheld vascular Doppler device for surgical and clinical use.
More than four years ago, company leaders took a deep dive into the functionality of a vascular Doppler device that had been used by top surgeons and clinicians for decades.
"Our team realized that traditional vascular equipment has an extensive list of inefficiencies, including long cables, poor quality speakers, and an unreliable battery source, to name a few," said Attly Aycock, CEO of Remington. "After reviewing the list of flaws that came with traditional vascular equipment, it was clear that the healthcare industry had an urgent need for a new and improved way to assess patient blood flow more effectively."
Multiple prototypes were created, and after choosing a design, the team interviewed more than 100 of the nation's top physicians and surgeons to ask if the vascular Doppler device would be a valuable addition to the market. The results were reviewed, and there was no doubt that the healthcare industry would benefit from a Remington vascular Doppler product.
The VascuChek Doppler System is designed and manufactured with a continuous 9 MHz wave system and takes up a fraction of the space of current Doppler system technology by eliminating the use of a large transceiver box with tethered probes and restrictive cords.
The device also offers a variety of other vascular screening advantages like cordless freedom and improved user control and reliability. VascuChek is intended for the intraoperative and transcutaneous evaluation of blood flow in a wide range of applications like intraoperative (microvascular and vascular), neurological, and peripheral vascular. The product s also intended for the non-invasive transcutaneous evaluation of blood flow.
Headquartered in Alpharetta, Georgia, Remington was founded by Fred L. Aycock in 1992. The company specializes in manufacturing medical devices and contract manufacturing services.
